Measurements of diagnostic examination performance and correlation analysis using microvascular leakage, cerebral blood volume, and blood flow derived from 3T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in glial tumor grading

Neuroradiology

Volumn 53, Issue 6, 2011, Pages 435-447

  Server, Andrés ^a,b   Graff, Bjørn A ^a   Orheim, Tone E Døli ^c   Schellhorn, Till ^a   Josefsen, Roger ^a   Gadmar, Øystein B ^c   Nakstad, Per H ^a,b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Brain neoplasms; DSC MR imaging; MR perfusion; MR permeability

Indexed keywords

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD VESSEL PERMEABILITY; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; BRAIN PERFUSION; CANCER GRADING; CANCER LOCALIZATION; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED STUDY; CORRELATIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROVASCULAR LEAKAGE; NERVOUS SYSTEM PARAMETERS; NEUROIMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SUSCEPTIBILITY WEIGHTED IMAGING; TUMOR DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; BRAIN; BRAIN NEOPLASMS; CEREBROVASCULAR CIRCULATION; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MICROVESSELS; MIDDLE AGED; NEOPLASM GRADING; PERFUSION; PROSPECTIVE STUDIES;

EID: 79959998425     PISSN: 00283940     EISSN: 14321920     Source Type: Journal    
DOI: 10.1007/s00234-010-0770-x     Document Type: Article

References (54)

1. PY Wen S Kesari 2008 Malignant gliomas in adults N Eng J Med 359 492 507 10.1056/NEJMra0708126 1:CAS:528:DC%2BD1cXpt1Sgsrw%3D
2. T Inoue K Ogasawara T Beppu A Ogawa H Kabasawa 2005 Diffusion tensor imaging for preoperative evaluation of tumor grade in gliomas Clin Neurol Neurosurg 107 174 180 15823671 10.1016/j.clineuro.2004.06.011
3. T Sugahara Y Korogi M Kochi I Ikushima Y Shigematu T Hirai T Okuda L Liang Y Ge Y Konohara Y Ushio M Takahashi 1999 Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas J Magn Reson Imaging 9 53 60 10030650 10.1002/(SICI)1522-2586(199901)9:1<53:: AID-JMRI7>3.0.CO;2-2 1:STN:280:DyaK1M7ltlOhsw%3D%3D (Pubitemid 29068231)
4. P Zonari P Baraldi G Crisi 2007 Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging Neuroradiology 49 795 803 17619871 10.1007/s00234-007-0253-x (Pubitemid 47497767)
5. E Goebell S Paustenbach O Vaeterlein XQ Ding O Heese J Fiehler T Kucinski C Hagel M Westphal H Zeumer 2006 Low-grade and anaplastic gliomas: differences in architecture evaluated with diffusion-tensor MR imaging Radiology 239 217 222 16484348 10.1148/radiol.2383050059
6. SM Chang MD Prados 1995 Chemotherapy for gliomas Curr Opin Oncol 7 207 213 7654821 10.1097/00001622-199505000-00003 1:CAS:528:DyaK2sXkt1amtrc%3D
7. P Krauseneck B Müller 1994 Chemotherapy of malignant gliomas Recent Results Cancer Res 135 135 147 7519355 1:STN:280:DyaK2czitlGgtA%3D%3D
8. S Bulnes J Bilbao JV Lafuente 2009 Microvascular adaptive changes in experimental endogenous brain gliomas Histol Histopathol 24 693 706 19337968 1:STN:280:DC%2BD1M3ltVWkuw%3D%3D
9. E Bullitt DA Reardon JK Smith 2007 A review of micro- and macrovascular analyses in the assessment of tumor-associated vasculature as visualized by MR Neuroimage 37 Suppl 1 S116 S119 17512217 10.1016/j.neuroimage.2007.03.067 (Pubitemid 47243807)
10. DJ Covarrubias BR Rosen MH Lev 2004 Dynamic magnetic resonance perfusion imaging of brain tumors Oncologist 9 528 537 15477637 10.1634/theoncologist.9-5- 528 (Pubitemid 39332316)
11. JM Provenzale GR Wang T Brenner, et al. 2002 Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging AJR Am J Roentgenol 178 711 716 11856703 (Pubitemid 34178155)
12. HC Roberts TPL Roberts RC Brasch WP Dillon 2000 Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade AJNR Am J Neuroradiol 21 891 899 10815665 1:STN:280:DC%2BD3c3ntlSrtQ%3D%3D (Pubitemid 30262836)
13. HJ Aronen J Perkio 2002 Dynamic susceptibility contrast MRI of gliomas Neuroimag Clin N Am 12 501 523 10.1016/S1052-5149(02)00026-6 (Pubitemid 36015488)
14. A Jackson A Kassner D Annesley-Williams H Reid XP Zhu KL Li 2002 Abnormalities in the recirculation phase of contrast agent bolus passage in cerebral gliomas: comparison with relative blood volume and tumor grade AJNR Am J Neuroradiol 23 7 14 11827869 (Pubitemid 34098254)
15. Louis DN, Ohgaki H, Wiestler OD, Carenee WK (eds) (2007) WHO Classification of tumors of the central nervous system. IARC, Lyon
16. MF Chernov O Kubo M Hayashi M Izawa T Maruyama M Usukura Y Ono T Hori K Takakura 2005 Proton MRS of the peritumoral brain J Neurol Sci 228 137 142 15694194 10.1016/j.jns.2004.11.039 1:CAS:528:DC%2BD2MXptlGrug%3D%3D (Pubitemid 40202958)
17. BR Rosen JW Belliveau JM Vevea TJ Brady 1990 Perfusion imaging with NMR contrast agents Magn Reson Med 14 249 265 2345506 10.1002/mrm.1910140211 1:STN:280:DyaK3c3msFamsQ%3D%3D (Pubitemid 20248610)
18. L Ostergaard RM Weisskoff DA Chesler C Gyldensted BR Rosen 1996 High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: mathematical approach and statistical analysis Magn Reson Med 36 715 725 8916022 10.1002/mrm.1910360510 1:STN:280:DyaK2s%2Fntlaktg%3D%3D (Pubitemid 26376710)
19. JL Boxerman KM Schmainda RM Weisskoff 2006 Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not AJNR Am J Neuroradiol 27 859 867 16611779 1:STN:280:DC%2BD283gsVGmuw%3D%3D (Pubitemid 44897737)
20. KE Emblem P Due-Tonnessen JK Hald A Bjornerud 2009 Automatic vessel removal in gliomas from dynamic susceptibility contrast imaging Magn Reson Med 61 1210 1217 19253390 10.1002/mrm.21944
21. SG Wetzel S Cha G Johnson P Lee M Law DL Kasow SD Pierce X Xue 2002 Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study Radiology 224 797 803 12202717 10.1148/radiol.2243011014 (Pubitemid 34919816)
22. ER Gerstner AG Sorensen RK Jain TT Batchelor 2008 Advances in neuroimaging techniques for the evaluation of tumor growth, vascular permeability, and angiogenesis in gliomas Curr Opin Neurol 21 728 735 18989120 10.1097/WCO.0b013e328318402a
23. AG Sorensen TT Batchelor PY Wen WT Zhang RK Jain 2008 Response criteria for glioma Nat Clin Pract Oncol 5 634 644 18711427 10.1038/ncponc1204
24. MC Tate MK Aghi 2009 Biology of angiogenesis and invasion in glioma Neurotherapeuthics 6 447 457 10.1016/j.nurt.2009.04.001 1:CAS:528: DC%2BD1MXhsFent7bN
25. R Jain SK Elika L Scarpace JP Rock J Gutierrez SC Patel J Ewing T Mikkelsen 2008 Quantitative estimation of permeability surface-area product in astroglial brain tumors using perfusion CT and correlation with histopathologic grade AJNR Am J Neuroradiol 29 694 700 18202239 10.3174/ajnr.A0899 1:STN:280:DC%2BD1c3js1OhtA%3D%3D (Pubitemid 351571548)
26. S Cha L Yang G Johnson A Lai MH Chen T Tihan M Wenderland WP Dillon 2006 Comparison of microvascular permeability measurements, K trans, determined with conventional steady-state T1-weighted and first-pass T2-weighted MR imaging methods in gliomas and meningiomas AJNR Am J Neuroradiol 27 409 417 16484420 1:STN:280:DC%2BD28%2Fps1Cntw%3D%3D (Pubitemid 44897852)
27. TF Patankar S Haroon SJ Mills D Balériaux DL Buckely GJ Parker A Jackson 2005 Is volume transfer coefficient (K (trans)) related to histologic grade in human gliomas? AJNR Am J Neuroradiol 26 2455 2465 16286385
28. M Law S Yang S Babb EA Knopp JG Golfinos D Zagzag G Johnson 2004 Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade AJNR Am J Neuroradiol 25 746 755 15140713 (Pubitemid 38657655)
29. MA Weber S Zoubaa M Schlieter E Jüttler HB Huttner K Geletneky C Ittrich MP Lichy A Kroll J Debus FL Giesel M Hartmann M Essig 2006 Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors Neurology 66 1899 1906 16801657 10.1212/01.wnl.0000219767.49705.9c 1:STN:280:DC%2BD28zosFKjuw%3D%3D (Pubitemid 44049824)
30. J Folkman 2006 Angiogenesis Annu Rev Med 57 1 18 16409133 10.1146/annurev.med.57.121304.131306 1:CAS:528:DC%2BD28Xis1Cksrg%3D (Pubitemid 43261975)
31. M Law R Young J Babb M Rad T Sasaki D Zagzag G Johnson 2006 Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade AJNR Am J Neuroradiol 27 1975 1982 17032878 1:STN:280:DC%2BD28ngtVChtw%3D%3D (Pubitemid 44556520)
32. W Stummer 2007 Mechanisms of tumor-related brain edema Neurosurg Focus 15 22 E8
33. T Engelhorn NE Savaskan MA Schwarz J Kreutzer EP Meyer E Hahnen O Ganslandt A Dörfler C Nimsky M Buchfelder IY Eyüpoglu 2009 Cellular characterization of the peritumoral edema zone in malignant brain tumors Cancer Sci 100 1856 1862 19681905 10.1111/j.1349-7006.2009.01259.x 1:CAS:528: DC%2BD1MXht12qs7jP
34. PA Stewart K Hayakawa E Hayakawa CL Farrell RF Del Maestro 1985 A quantitative study of blood-brain barrier permeability ultrastructure in a new rat glioma model Acta Neuropathol 67 96 102 4024875 10.1007/BF00688129 1:STN:280:DyaL2M3nsFejtQ%3D%3D (Pubitemid 15021216)
35. R Young J Babb M Law E Pollack G Johnson 2007 Comparison of region-of-interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas J Magn Reson Imaging 26 1053 1063 17896374 10.1002/jmri.21064 (Pubitemid 47548167)
36. M Law R Young J Babb E Pollack G Johnson 2007 Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas AJNR Am J Neuroradiol 28 761 766 17416835 1:STN:280:DC%2BD2s3htleqtw%3D%3D (Pubitemid 46608621)
37. KE Emblem B Nedregaard T Nome P Due-Tonnessen JK Hald D Scheie OC Borota M Cvancarova A Bjornerud 2008 Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps Radiology 247 808 817 18487536 10.1148/radiol.2473070571
38. H Järnum EG Steffensen L Knutsson ET Fründ CW Simonsen S Lundbye-Christensen A Shankaranarayanan DC Alsop FT Jensen EM Larsson 2010 Perfusion MRI of brain tumours: a comparative study of pseudo-continuous arterial spin labelling and dynamic susceptibility contrast imaging Neuroradiology 52 307 317 19841916 10.1007/s00234-009-0616-6
39. M Haris N Husain A Singh M Husain S Srivastava C Srivastava S Behari RK Rathore S Sakjena RK Gupta 2008 Dynamic contrast-enhanced derived cerebral blood volume correlates better with leak correction than with no correction for vascular endothelial growth factor, microvascular density, and grading of astrocytoma J Comp Assist Tomogr 32 955 965 10.1097/RCT.0b013e31816200d1
40. JC Miller HH Pien D Sahani AG Sorensen JH Thrall 2005 Imaging angiogenesis: applications and potential for drug development J Natl Cancer Inst 97 172 187 15687360 10.1093/jnci/dji023 1:CAS:528:DC%2BD2MXhtV2qsL8%3D (Pubitemid 40277367)
41. L Ostergaard FH Hochberg JD Rabinov AG Sorensen M Lev L Kim RM Weisskoff RG Gonzalez C Gyldensted BR Rosen 1999 Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors J Neurosurg 90 300 305 9950501 10.3171/jns.1999.90.2.0300 1:STN:280: DyaK1M7jsVSjsg%3D%3D (Pubitemid 29068132)
42. DM McDonald PL Choyke 2003 Imaging of angiogenesis: from microscope to clinic Nat Med 9 713 725 12778170 10.1038/nm0603-713 1:CAS:528: DC%2BD3sXktFOnurs%3D (Pubitemid 36749220)
43. ZM Bhujwalla D Artemov K Natarajan M Solaiyappan P Kollars PE Kristjansen 2003 Reduction of vascular and permeable regions in solid tumors detected by macromolecular contrast magnetic resonance imaging after treatment with antiangiogenic agent TNP-470 Clin Cancer Res 9 355 362 12538488 1:CAS:528:DC%2BD3sXnt1Oqsg%3D%3D (Pubitemid 36109752)
44. LS Hu LC Baxter GE Pinnaduwage TL Paine JP Karis BG Feurstein KM Schmainda AC Dueck J Debbins KA Smith P Nakaji JM Eschbacher SW Coons JE Heiserman 2010 Optimized preload leakage-correction methods to improve the diagnostic accuracy of dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in posttreatment gliomas AJNR Am J Neuroradiol 31 40 48 19749223 10.3174/ajnr.A1787 1:STN:280:DC%2BC3c%2FisFSrtw%3D%3D
45. L Lüdemann C Warmuth M Plotkin A Förschler M Gutberlet P Wust H Amthauer 2009 Brain tumor perfusion: comparison of dynamic contrast enhanced magnetic resonance imaging using T1, T2, and T2 contrast, pulsed arterial spin labelling, and H2(15)O positron emission tomography Eur J Radiol 70 465 474 18359598 10.1016/j.ejrad.2008.02.012
46. ES Paulson KM Schmainda 2008 Comparison of dynamic susceptibility- weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors Radiology 249 601 613 18780827 10.1148/radiol.2492071659
47. A Server TE Orheim BA Graff R Josefsen T Kumar PH Nakstad 2010 Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and brain metastasis Neuroradiology 10.1007/s00234-010-0740-3
48. E Matsusue JR Fink JK Rockhill T Ogawa KR Maravilla 2010 Distinction between glioma progression and post-radiation change by combined physiologic MR imaging Neuroradiology 52 297 306 19834699 10.1007/s00234-009-0613-9
49. JM Levin LL Wald MJ Kaufman MH Ross LC Maas PF Renshaw 1998 T1 effects in sequential dynamic susceptibility contrast experiments J Magn Reson 130 292 295 9500901 10.1006/jmre.1997.1317 1:CAS:528:DyaK1cXhslansbc%3D (Pubitemid 128451240)
50. VM Runge JE Kirsch JW Wells JN Dunworth L Hilaire CE Woolfolk 1994 Repeat cerebral blood volume assessment with first-pass MR imaging J Magn Reson Imaging 4 457 461 8061447 10.1002/jmri.1880040335 1:STN:280:DyaK2czjvFKiuw%3D%3D
51. JM Levin MJ Kaufman MH Ross JH Mendelson LC Maas BM Cohen PF Renshaw 1995 Sequential dynamic susceptibility contrast MR experiments in human brain: residual contrast agent effect, steady state, and hemodynamic perturbation Magn Reson Med 34 655 663 8544685 10.1002/mrm.1910340503 1:STN:280: DyaK287jtVKhsw%3D%3D
52. RF Barajas JS Chang MR Segal AT Parsa MW McDermott MS Berger S Cha 2009 Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging Radiology 253 486 496 19789240 10.1148/radiol.2532090007
53. N Bulakbasi M Kocaoglu A Farzaliyev U Tayfun T Ucoz I Somuncu 2005 Assessment of diagnostic accuracy of perfusion MR imaging in primary and metastatic solitary malignant brain tumors AJNR Am J Neuroradiol 26 2187 2199 16219821
54. JH Shin BD Kwun JS Kim CG Choi DC Sub 2002 Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results AJR Am J Roentgenol 179 783 789 12185064 (Pubitemid 34919600)